World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
31405
World Ranking
8933
National Ranking
3967

Overview

Isabelle Riviere is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions notably in Oncology, Molecular Biology, Immunology, Electrical and Electronic Engineering, and Genetics.

The scientist's main research topics include:

  • CAR-T cell therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Biosimilars and Bioanalytical Methods
  • CRISPR and Genetic Engineering
  • Advancements in Semiconductor Devices and Circuit Design
  • Virus-based gene therapy research
  • Immune Cell Function and Interaction

Frequent coauthors collaborating with Isabelle Riviere include Michel Sadelain, Jae H. Park, Renier J. Brentjens, Xiuyan Wang, and Brigitte Sénéchal.

Their recent notable publications are:

  • A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab (2021, Cancer Discovery)
  • GPRC5D-Targeted CAR T Cells for Myeloma (2022, New England Journal of Medicine)
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy (2022, Nature Medicine)
  • Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01 (2021, Cell stem cell)
  • HLA-independent T cell receptors for targeting tumors with low antigen density (2022, Nature Medicine)

Isabelle Riviere frequently publishes in journals such as Blood, Nature Medicine, Clinical Lymphoma Myeloma & Leukemia, Cancer Discovery, and Cell stem cell, with Blood hosting the majority of their work.

Best Publications

  • Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    Marco L. Davila;Isabelle Riviere;Xiuyan Wang;Shirley Bartido

  • Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

    Jae H. Park;Isabelle Rivière;Mithat Gonen;Xiuyan Wang

  • CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

    Renier J. Brentjens;Marco L. Davila;Isabelle Riviere;Jae Park

  • The Basic Principles of Chimeric Antigen Receptor Design

    Michel Sadelain;Renier Brentjens;Isabelle Rivière

  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

    Renier J. Brentjens;Isabelle Rivière;Jae H. Park;Marco L. Davila

  • Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

    John Maher;Renier J Brentjens;Gertrude Gunset;Isabelle Rivière

  • Therapeutic T cell engineering

    Michel Sadelain;Isabelle Rivière;Stanley Riddell

  • Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

    Renier J. Brentjens;Jean Baptiste Latouche;Elmer Santos;Francesc Marti

  • Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.

    Bianca D. Santomasso;Jae H. Park;Darin Salloum;Isabelle Riviere

  • The promise and potential pitfalls of chimeric antigen receptors

    Michel Sadelain;Renier Brentjens;Isabelle Rivière

  • Targeting tumours with genetically enhanced T lymphocytes

    Michel Sadelain;Isabelle Rivière;Renier Brentjens

  • Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

    Xiao Song Zhong;Maiko Matsushita;Jason Plotkin;Isabelle Riviere

  • Clinical manufacturing of CAR T cells: foundation of a promising therapy

    Xiuyan Wang;Isabelle Rivière

  • Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial

    Renier Brentjens;Raymond Yeh;Yvette Bernal;Isabelle Riviere

  • Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

    Isabelle Riviere;Katja Brose;Richard C. Mulligan

  • A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.

    Prasad S. Adusumilli;Marjorie G. Zauderer;Isabelle Rivière;Stephen B. Solomon

  • CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

    Mohamad Hamieh;Anton Dobrin;Annalisa Cabriolu;Sjoukje J. C. van der Stegen

  • Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.

    Daniel Hollyman;Jolanta Stefanski;Mark Przybylowski;Shirley Bartido

  • Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.

    Philip J. Bergman;Joanne McKnight;Andrew Novosad;Sarah Charney

  • Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells

    Eirini P Papapetrou;Gabsang Lee;Nirav Malani;Manu Setty

Frequent Co-Authors

Michel Sadelain
Michel Sadelain Columbia University
Renier J. Brentjens
Renier J. Brentjens Roswell Park Cancer Institute
Richard J. O'Reilly
Richard J. O'Reilly Memorial Sloan Kettering Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Nancy A. Kernan
Nancy A. Kernan Memorial Sloan Kettering Cancer Center
Glenn Heller
Glenn Heller Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Jianda Yuan
Jianda Yuan MSD (United States)
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Richard C. Mulligan
Richard C. Mulligan Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A strong background in biology and biochemistry opens doors to numerous specialized online degree programs and career options in healthcare and related fields. For students seeking to advance their expertise quickly, there are accelerated dietitian programs that cover essential topics like human nutrition and metabolic biochemistry—making it possible to become a registered dietitian in less time.

Those interested in mental health and advanced nursing roles may pursue psych np programs. These programs are designed for nurses who want to specialize in psychiatric and mental health care, and often build upon core scientific knowledge.

Alternatively, a scientific background pairs well with an mba healthcare management online, equipping graduates with leadership and business skills needed in hospitals, biotech firms, and research organizations.

For those considering medical coding or data management, understanding the differences in ccs certification is crucial. Certification can enhance credentials, increase salary prospects, and offer flexibility in the rapidly growing health informatics sector.

Best Scientists Citing Isabelle Riviere

Trending Scientists

Recently Published Articles